12 Results

People

  1. Bartido
    Bartido
  2. O'Reilly
    O'Reilly
  3. Sadelain
    Sadelain
  4. Wang
    Wang
  5. Ambati
    Ambati
  6. Boulad
    Boulad
  7. Chiosis
    Chiosis
  8. Curran
    Curran
  9. Heller
    Heller
  10. Mony
    Mony

Groups

  1. Center for Hematologic Malignancies (12)
  2. GSK Faculty (12)
  3. Hematologic Malignancies Research (12)
  4. Pediatrics, Department of (12)
  5. Sloan Kettering Institute Faculty (12)
  6. Molecular Pharmacology and Chemistry Program Faculty (10)
  7. Department of Medicine (8)
  8. Hematologic Malignancies, Division of (8)
  9. Stem Cell Transplantation and Cellular Therapy Service (8)
  10. Tow Center for Developmental Oncology (TCDO) (5)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Pediatrics, Department of"
  4. "2013"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (3)
Groups
  1. Center for Hematologic Malignancies (12)
  2. GSK Faculty (12)
  3. Hematologic Malignancies Research (12)
  4. Pediatrics, Department of (12)
  5. Sloan Kettering Institute Faculty (12)
  6. Molecular Pharmacology and Chemistry Program Faculty (10)

More Groups

People
  1. Farid Boulad (4)
  2. Isabelle Riviere (4)
  3. Michel Sadelain (4)
  4. Richard O'Reilly (4)
  5. Shirley Bartido (4)
  6. Susan Prockop (4)

More People

Years
  1. 2013 (12)
Publications
  1. Blood (5)
  2. Science Translational Medicine (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Cancer Research (1)
  5. Journal of Clinical Oncology (1)
  6. Molecular Therapy (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. American Association for the Advancement of Science (2)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Inc. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activity of PU-H71, a novel HSP90 inhibitor, and bortezomib in Ewing sarcoma preclinical models
    Meeting Abstract

    Ambati, S. R.; Lopes, E. C.; Kosugi, K.; Mony, U.; Zehir, A.; Moreira, A. L.; Meyers, P. A.; Chiosis, G.; Moore, M. A. S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A bi-specific T cell engaging monoclonal antibody (mAb) derived from a TCR-Like mAB specific for WT1/HLA-A0201 (ESK-BiTE) shows a potent activity against human AML and Ph+ ALL in mouse models
    Meeting Abstract

    Pankov, D.; Dao, T.; Wang, Y.; Scott, A.; Korontsvit, T.; Zakhaleva, V.; Veomett, N.; Curcio, M.; Doubrovina, E.; O'Reilly, R. J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Targeting oncogenic interleukein-7 receptor signaling with N-acetylcysteine in T-cell acute lymphoblastic leukemia
    Meeting Abstract

    Mansour, M. R.; Reed, C.; Eisenberg, A.; Tseng, J. C.; Yoda, A.; Rodig, S. J.; DeAngelo, D. J.; Sallan, S. E.; Weinstock, D. M.; Izraeli, S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Safe and effective re-induction of complete remissions in adults with relapsed B-ALL using 19-28z CAR CD19-targeted T cell therapy
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Taylor, C.; Wasielewska, T.; Qu, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • First US phase I clinical trial of globin gene transfer for the treatment of beta-thalassemia major
    Meeting Abstract

    Boulad, F.; Riviere, I.; Wang, X.; Bartido, S.; Prockop, S. E.; Barone, R.; Moi, P.; Maggio, A.; Sadelain, M.
    Blood (2013)

    Fulltext@MSK | Save
  • Novel inhibitor of HSP90-PU-H71 exhibits significant activity in Ewing sarcoma pre-clinical models
    Meeting Abstract

    Ambati, S. R.; Caldas Lopes- Vazquez, M. E.; Mony, U.; Kosugi, K.; Moreira, A.; Meyers, P.; Chiosis, G.; Moore, M.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Safe G-CSF mobilization of thalassemia patient CD34+cells and effective globin gene transduction for therapeutic infusion
    Meeting Abstract

    Boulad, F.; Wang, X. Y.; Taylor, C.; Qu, J. R.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Molecular Therapy (2013)

    Fulltext@MSK | Save
  • Novel purine scaffold Hsp90 inhibitor Pu-H71, exhibits significant activity in Ewing sarcoma pre-clinical models
    Meeting Abstract

    Ambati, S.; Lopes, E. C.; Kosugi, K.; Mony, U.; Peguero, E.; Moreira, A.; Meyers, P.; Chiosis, G.; Moore, M.
    Pediatric Blood and Cancer (2013)

    Fulltext@MSK | Save
  • CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
    Journal Article

    Brentjens, R. J.; Davila, M. L.; Riviere, I.; Park, J.; Wang, X.; Cowell, L. G.; Bartido, S.; Stefanski, J.; Taylor, C.; Olszewska, M.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save